Answers are grounded in this paper and cite their sources.
Twenty-nine overweight schizophrenic patients maintained on depot neuroleptic injections who wished to lose weight took part in a double-blind, placebo-controlled trial of 30 mg D-fenfluramine. All subjects received dietary advice. Sixteen patients completed the 12-week trial. Rate of weight loss was significantly greater in those taking D-fenfluramine. Side-effects were reported, but no deterioration in mental state was noted.
No takes yet. Share an insight, caveat, or question.
Goodall et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: